We are live on ! Find out more
EPM

Equitec Proprietary Markets Portfolio holdings

AUM $559M
1-Year Est. Return 230.29%
This Fund
S&P 500
This Quarter Est. Return
-8.03%
1 Year Est. Return
+230.29%
3 Year Est. Return
+526.89%
5 Year Est. Return
+679.16%
10 Year Est. Return
AUM
$315M
AUM Growth
-$64.1M
Cap. Flow
-$15.6M
Cap. Flow %
-4.94%
Top 10 Hldgs %
65.01%
Holding
323
New
39
Increased
32
Reduced
45
Closed
116

Top Buys

Rank Stock Value
1
FRG
Franchise Group, Inc.
FRG
+$7.26M
2
IVV icon
iShares Core S&P 500 ETF
IVV
+$6.95M
3
TSLA icon
Tesla
TSLA
+$6.51M
4
DNA icon
Ginkgo Bioworks
DNA
+$4.13M
5
AMZN icon
Amazon
AMZN
+$3.09M

Sector Composition

Rank Sector Weight
1 Financials 15.66%
2 Industrials 13.47%
3 Technology 4.87%
4 Healthcare 2.89%
5 Consumer Discretionary 2.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GBT
301
DELISTED
Global Blood Therapeutics, Inc.
GBT
-13,800
Closed -$940K
GBT
302
PUT
DELISTED
Global Blood Therapeutics, Inc.
GBT
-12,200
Closed -$831K
BRG
303
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
-103,257
Closed -$2.76M
BRG
304
PUT
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
-222,300
Closed -$5.95M
HNGR
305
DELISTED
Hanger Inc.
HNGR
-100
Closed -$2K
HNGR
306
PUT
DELISTED
Hanger Inc.
HNGR
-2,000
Closed -$37K
CHNG
307
CALL
DELISTED
Change Healthcare Inc. Common Stock
CHNG
-4,900
Closed -$135K
CHNG
308
DELISTED
Change Healthcare Inc. Common Stock
CHNG
-125,800
Closed -$3.46M
CHNG
309
PUT
DELISTED
Change Healthcare Inc. Common Stock
CHNG
-173,800
Closed -$4.78M
NMMCW
310
DELISTED
North Mountain Merger Corp. Warrant
NMMCW
-15,000
Closed
CTXS
311
CALL
DELISTED
Citrix Systems Inc
CTXS
-5,300
Closed -$551K
CTXS
312
DELISTED
Citrix Systems Inc
CTXS
-54,300
Closed -$5.64M
CTXS
313
PUT
DELISTED
Citrix Systems Inc
CTXS
-93,600
Closed -$9.72M
XELA
314
DELISTED
Exela Technologies, Inc. Common Stock
XELA
-349
Closed -$32K
TRQ
315
CALL
DELISTED
Turquoise Hill Resources Ltd
TRQ
-100
Closed -$3K
TRQ
316
PUT
DELISTED
Turquoise Hill Resources Ltd
TRQ
-52,300
Closed -$1.55M
NLSN
317
CALL
DELISTED
Nielsen Holdings plc
NLSN
-4,100
Closed -$114K
NLSN
318
DELISTED
Nielsen Holdings plc
NLSN
-27,300
Closed -$757K
NLSN
319
PUT
DELISTED
Nielsen Holdings plc
NLSN
-31,700
Closed -$879K
BHVN
320
CALL
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
-16,600
Closed -$2.51M
BHVN
321
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
-94,350
Closed -$14.3M
BHVN
322
PUT
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
-187,100
Closed -$28.3M
FIEE
323
FiEE Inc
FIEE
$25.5M
-15,200
Closed -$80K

Similar funds

Equitec Proprietary Markets's Q4 2022 Portfolio in Review

As of Q4 2022, Equitec Proprietary Markets held 323 positions worth $315M, down 17% from $380M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Equitec Proprietary Markets withdrew a net $15.6M in Q4 2022, closing 116 positions and reducing 45 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $14.3M position sold in full.

By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 18% a quarter earlier, followed by Industrials and Technology.

Against the trend, Equitec Proprietary Markets opened a new position in iShares Core S&P 500 ETF worth $6.92M.

  • Equitec Proprietary Markets's largest Q4 2022 buy was iShares Core S&P 500 ETF: 18,000 shares worth $6.92M.
  • Equitec Proprietary Markets added most to Franchise Group, Inc. in Q4 2022, an estimated $7.26M increase.
  • Equitec Proprietary Markets's biggest Q4 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $12.3M.
  • Equitec Proprietary Markets fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $14.3M.
  • Equitec Proprietary Markets's ten largest holdings make up 65% of its $315M portfolio in Q4 2022.
  • Equitec Proprietary Markets opened 39 new positions and closed 116 in Q4 2022.
  • Equitec Proprietary Markets's portfolio value fell 17% quarter-over-quarter to $315M.

Based on Equitec Proprietary Markets's 13F filing for Q4 2022, filed 31 Jan 2023.